A Research Study of a New Medicine NNC0113-6856 in Healthy Males

NCT05521256 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Type 2 Diabetes

Interventions

DRUG: NNC0113-6856
DRUG: Placebo

Sponsor

Novo Nordisk A/S